Risperdal Consta & Gynaecomastia

9.7%

of users reported Gynaecomastia

94.8%

also reported Severe reaction

100.0%

are men

Severe reaction

94.8%

Hospitalization

5.2%

Risperdal Consta: general information

0 - 9 years

0.3%

10 - 19 years

6.7%

20 - 29 years

22.0%

30 - 39 years

22.2%

40 - 49 years

16.4%

50 - 59 years

17.0%

60 - 69 years

10.9%

70 - 79 years

3.5%

80 - 89 years

1.0%